Rezultati - Shlomo Flechter
- Showing 1 - 9 results of 9
-
1
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies od Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich
Izdano 2021Artigo -
2
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod od Anat Achiron, Mathilda Mandel, Michael Gurevich, Sapir Dreyer-Alster, David Magalashvili, Polina Sonis, Mark Dolev, Shay Menascu, Gil Harari, Shlomo Flechter, Rina Falb
Izdano 2022Artigo -
3
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study od Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, Mark Dolev, Shay Menascu, David Magalashvili, Shlomo Flechter, Uri Givon, Diana Guber, Polina Sonis, Rina Zilkha‐Falb, Michael Gurevich
Izdano 2021Artigo -
4
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021 od Anat Achiron, Mark Dolev, Shay Menascu, Daniela-Noa Zohar, Sapir Dreyer-Alster, Shmuel Miron, Emanuel Shirbint, David Magalashvili, Shlomo Flechter, Uri Givon, Diana Guber, Yael Stern, Michael Polliack, Rina Falb, Michael Gurevich
Izdano 2021Artigo -
5
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose od Sapir Dreyer-Alster, Shay Menascu, Mathilda Mandel, Emanuel Shirbint, David Magalashvili, Mark Dolev, Shlomo Flechter, Uri Givon, Diana Guber, Yael Stern, Shmuel Miron, Michael Polliack, Rina Falb, Polina Sonis, Michael Gurevich, Anat Achiron
Izdano 2022Artigo -
6
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude od Jeannette Lechner‐Scott, Benjamin Spencer, Theo de Malmanche, John Attia, Margaret Fitzgerald, María Trojano, François Grand’Maison, Jessica Gómez, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Pierre Grammond, Celia Oreja‐Guevara, Raymond Hupperts, Roberto Bergamaschi, Cavit Boz, Giorgio Giuliani, Vincent Van Pesch, Gerardo Iuliano, M. Fiol, Edgardo Cristiano, F. Verheul, Maria Luisa Saladino, Mark Slee, Michael Barnett, Norma Deri, Shlomo Flechter, Norbert Vella, Christopher S. Shaw, Joseph Herbert, Fraser Moore, Tatjana Petkovska‐Boskova, Vilija Jokubaitis, Helmut Butzkueven
Izdano 2011Artigo -
7
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis od Nathaniel Lizak, Alessandra Lugaresi, Raed Alroughani, Jeannette Lechner‐Scott, Mark Slee, Eva Havrdová, Dana Horáková, María Trojano, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Alexandre Prat, Pierre Grammond, Raymond Hupperts, François Grand’Maison, Patrizia Sola, Eugenio Pucci, Roberto Bergamaschi, Celia Oreja‐Guevara, Vincent Van Pesch, Cristina Ramo‐Tello, Daniele Spitaleri, Gerardo Iuliano, Cavit Boz, Franco Granella, Javier Olascoaga, Freek Verheul, Csilla Rózsa, Edgardo Cristiano, Shlomo Flechter, Suzanne Hodgkinson, Maria Pia Amato, Norma Deri, Vilija Jokubaitis, Tim Spelman, Helmut Butzkueven, Tomáš Kalinčík
Izdano 2016Artigo -
8
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response od Tomáš Kalinčík, Ali Manouchehrinia, Lukáš Sobíšek, Vilija Jokubaitis, Tim Spelman, Dana Horáková, Eva Havrdová, María Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Marc Girard, Alexandre Prat, Pierre Duquette, Pierre Grammond, Patrizia Sola, Raymond Hupperts, François Grand’Maison, Eugenio Pucci, Cavit Boz, Raed Alroughani, Vincent Van Pesch, Jeannette Lechner‐Scott, Murat Terzi, Roberto Bergamaschi, Gerardo Iuliano, Franco Granella, Daniele Spitaleri, Vahid Shaygannejad, Celia Oreja‐Guevara, Mark Slee, Radek Ampapa, Freek Verheul, Pamela McCombe, Javier Olascoaga, Maria Pia Amato, Steve Vucic, Suzanne Hodgkinson, Cristina Ramo‐Tello, Shlomo Flechter, Edgardo Cristiano, Csilla Rózsa, Fraser Moore, José Luis Sánchez-Menoyo, Maria Luisa Saladino, Michael Barnett, Jan Hillert, Helmut Butzkueven
Izdano 2017Artigo -
9
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis od Tomáš Kalinčík, V. Vivek, Vilija Jokubaitis, Jeannette Lechner‐Scott, María Trojano, Guillermo Izquierdo, Alessandra Lugaresi, François Grand’Maison, Raymond Hupperts, Celia Oreja‐Guevara, Roberto Bergamaschi, Gerardo Iuliano, Raed Alroughani, Vincent Van Pesch, Maria Pia Amato, Mark Slee, Freek Verheul, Ricardo Fernández‐Bolaños, Marcela Fiol, Daniele Spitaleri, Edgardo Cristiano, Orla Gray, José Antonio Cabrera-Gómez, Vahid Shaygannejad, Joseph Herbert, Steve Vucic, Merrilee Needham, Tatjana Petkovska‐Boskova, Carmen Adella Sîrbu, Pierre Duquette, Marc Girard, Pierre Grammond, Cavit Boz, Giorgio Giuliani, Maria Edite Rio, Michael Barnett, Shlomo Flechter, Fraser Moore, Bhim Singhal, Elizabeth Alejandra Bacile Bacile, Maria Luisa Saladino, Cameron Shaw, Eli Skromne, Dieter Poehlau, Norbert Vella, Timothy Spelman, Danny Liew, Trevor J. Kilpatrick, Helmut Butzkueven
Izdano 2013Artigo
Iskalna orodja:
Sorodne teme
Medicine
Multiple sclerosis
Immunology
Internal medicine
Cohort
Fingolimod
Immune system
Vaccination
Disease
Natalizumab
Adverse effect
Antibody
Cladribine
Discontinuation
Expanded Disability Status Scale
Gastroenterology
Ocrelizumab
Pediatrics
Rituximab
Age of onset
Alemtuzumab
Biology
Booster dose
Cellular immunity
Cerebrospinal fluid
Clinical trial
Cohort study
Context (archaeology)
Coronavirus disease 2019 (COVID-19)
Cross-sectional study